ACORN CREEK CAPITAL LLC

Position in LLY — ELI LILLY & Co

CIK 1994827 FORT COLLINS, CO

Position in LLY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,270,196

+$247,412 QoQ

Shares Held

1,059

-4.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.33%

of 13F equity value

Holder Rank

#2,910

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ACORN CREEK CAPITAL LLC holds $3,422,772 across 6 Drug Manufacturers - General names. LLY ranks #1 (37.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,059	$1,270,196
2	NVS	Novartis AG	3,727	$584,095
3	ABBV	AbbVie Inc.	2,237	$562,918
4	JNJ	Johnson & Johnson	2,133	$541,718
5	MRK	Merck & Co., Inc.	1,895	$243,507
6	AZN	Astrazeneca PLC	1,162	$220,338

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,270,196	1,059	-4.8%	Shares	Sole	2026-08-06
2026-03-31	$1,022,784	1,112	-3.6%	Shares	Sole	2026-05-12
2025-12-31	$1,240,180	1,154	+34.3%	Shares	Sole	2026-02-02
2025-09-30	$655,417	859	+1.2%	Shares	Sole	2025-11-06
2025-06-30	$661,820	849	-4.8%	Shares	Sole	2025-07-25
2025-03-31	$736,711	892	-3.1%	Shares	Sole	2025-04-22
2024-12-31	$711,012	921	-1.3%	Shares	Sole	2025-01-22
2024-09-30	$826,582	933	+0.6%	Shares	Sole	2024-10-15
2024-06-30	$839,287	927	+1.3%	Shares	Sole	2024-07-18
2024-03-31	$711,833	915	+0.3%	Shares	Sole	2024-04-24
2023-12-31	$531,623	912	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.